Paul Tudor Jones’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.7M Buy
123,700
+59,600
+93% +$15.8M 0.08% 171
2026
Q1
$7.03M Buy
64,100
+34,400
+116% +$4.9M 0.01% 957
2025
Q4
$4.94M Sell
29,700
-123,800
-81% -$20.7M 0.01% 1158
2025
Q3
$30.1M Buy
153,500
+50,400
+49% +$8.29M 0.05% 293
2025
Q2
$9.32M Sell
103,100
-102,700
-50% -$8.11M 0.02% 702
2025
Q1
$12.3M Buy
205,800
+197,300
+2,321% +$18.3M 0.04% 383
2024
Q4
$1.13M Sell
8,500
-700
-8% -$65.7K ﹤0.01% 1654
2024
Q3
$482K Buy
+9,200
New +$432K ﹤0.01% 2056

Other funds holding ALAB

Paul Tudor Jones's ALAB Position: Q2 2026 in Review

Paul Tudor Jones increased its Astera Labs (ALAB) stake by 867% in Q2 2026, buying an estimated $85.9M and bringing the position to 361,000 shares worth $174M. The position accounts for 0.24% of the portfolio, ranked #59.

Paul Tudor Jones first reported a position in ALAB in Q1 2024 and has held it in 8 quarters since. 984 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Paul Tudor Jones held 361,000 shares of Astera Labs worth $174M as of Q2 2026.
  • Paul Tudor Jones bought 323,654 Astera Labs shares in Q2 2026, an estimated $85.9M.
  • Astera Labs made up 0.24% of Paul Tudor Jones's portfolio in Q2 2026, its #59 holding.
  • Paul Tudor Jones first reported a position in Astera Labs in Q1 2024 and has held it in 8 quarters since.
  • 984 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.